Healthcare provider profile · identity verified

Howard M Leroux, MD

Family Practice · N MUSKEGON, MI · NPI 1316939176

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	559	156
Omeprazole	Omeprazole	410	123
Lisinopril	Lisinopril	382	110
Levothyroxine Sodium	Levothyroxine Sodium	340	85
Amlodipine Besylate	Amlodipine Besylate	272	77
Metformin Hcl	Metformin Hcl	261	73
Losartan Potassium	Losartan Potassium	242	75
Hydrochlorothiazide	Hydrochlorothiazide	197	54
Rosuvastatin Calcium	Rosuvastatin Calcium	181	64
Metoprolol Succinate	Metoprolol Succinate	176	50
Duloxetine Hcl	Duloxetine Hcl	170	42
Gabapentin	Gabapentin	163	46
Eliquis	Apixaban	156	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	156	50
Tramadol Hcl	Tramadol Hcl	144	28
Albuterol Sulfate Hfa	Albuterol Sulfate	143	64
Tamsulosin Hcl	Tamsulosin Hcl	129	42
Pravastatin Sodium	Pravastatin Sodium	124	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	121	22
Meloxicam	Meloxicam	109	37
Prednisone	Prednisone	109	33
Simvastatin	Simvastatin	108	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	18
Atenolol	Atenolol	100	31
Mounjaro	Tirzepatide	99	17
Zolpidem Tartrate	Zolpidem Tartrate	94	16
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	90	suppressed
Metformin Hcl Er	Metformin Hcl	90	28
Carvedilol	Carvedilol	89	30
Fluoxetine Hcl	Fluoxetine Hcl	85	26
Metoprolol Tartrate	Metoprolol Tartrate	80	23
Sertraline Hcl	Sertraline Hcl	79	23
Doxazosin Mesylate	Doxazosin Mesylate	77	23
Buspirone Hcl	Buspirone Hcl	75	20
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	75	21
Ozempic	Semaglutide	70	16
Potassium Chloride	Potassium Chloride	69	20
Pantoprazole Sodium	Pantoprazole Sodium	68	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	20
Furosemide	Furosemide	65	28
Escitalopram Oxalate	Escitalopram Oxalate	64	16
Glimepiride	Glimepiride	64	17
Ibuprofen	Ibuprofen	64	23
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	60	29
Pioglitazone Hcl	Pioglitazone Hcl	60	18
Finasteride	Finasteride	57	20
Lovastatin	Lovastatin	55	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	18
Montelukast Sodium	Montelukast Sodium	51	15
Citalopram Hbr	Citalopram Hydrobromide	50	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	12
Lorazepam	Lorazepam	49	17
Allopurinol	Allopurinol	48	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	13
Celecoxib	Celecoxib	46	16
Trazodone Hcl	Trazodone Hcl	46	15
Pregabalin	Pregabalin	43	11
Aripiprazole	Aripiprazole	40	suppressed
Baclofen	Baclofen	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Mirtazapine	Mirtazapine	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	37	suppressed
Clonazepam	Clonazepam	37	suppressed
Estradiol	Estradiol	37	15
Trulicity	Dulaglutide	37	suppressed
Bumetanide	Bumetanide	36	11
Famotidine	Famotidine	36	suppressed
Alprazolam	Alprazolam	35	suppressed
Ibu	Ibuprofen	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	11
Meclizine Hcl	Meclizine Hcl	34	15
Naproxen	Naproxen	34	14
Spironolactone	Spironolactone	34	11
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Diazepam	Diazepam	33	12
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	12
Alendronate Sodium	Alendronate Sodium	30	14
Donepezil Hcl	Donepezil Hcl	30	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	30	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Hydrocortisone	Hydrocortisone	26	19
Temazepam	Temazepam	26	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Torsemide	Torsemide	24	suppressed
Nitroglycerin	Nitroglycerin	23	15
Bupropion Xl	Bupropion Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	14
Ezetimibe	Ezetimibe	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Valsartan	Valsartan	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Dulera	Mometasone/Formoterol	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Tramadol Hcl Er	Tramadol Hcl	14	suppressed
Fentanyl	Fentanyl	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Austedo Xr	Deutetrabenazine	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Humalog Kwikpen U-200	Insulin Lispro	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error